Global Opioids Drugs Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Publisher Name :
Date: 29-Oct-2020
No. of pages: 114

The Opioids Drugs market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Opioids Drugs market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Opioids Drugs market. The report focuses on well-known providers in the global Opioids Drugs industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Opioids Drugs Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Opioids Drugs market covered in Chapter 4:

Allergan

Orexo Pharmaceuticals

Purdue Pharma

Pfizer

AbbVie

Teva pharmaceuticals

Johnson & Johnson

Endo Pharmaceuticals

Sanofi-aventis US LLC

Hospira

In Chapter 11 and 13.3, on the basis of types, the Opioids Drugs market from 2015 to 2026 is primarily split into:

Oxycodone (e.g., OxyContin, Percocet)

Hydrocodone (e.g., Vicodin)

Codeine

Morphine (e.g., Kadian, Avinza)

Others

In Chapter 12 and 13.4, on the basis of applications, the Opioids Drugs market from 2015 to 2026 covers:

Neuropathic pain treatment

Orthopedic pain treatment

Other pain treatment

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Global Opioids Drugs Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Opioids Drugs Market Share by Type (2020-2026)
1.5.2 Oxycodone (e.g., OxyContin, Percocet)
1.5.3 Hydrocodone (e.g., Vicodin)
1.5.4 Codeine
1.5.5 Morphine (e.g., Kadian, Avinza)
1.5.6 Others
1.6 Market by Application
1.6.1 Global Opioids Drugs Market Share by Application (2020-2026)
1.6.2 Neuropathic pain treatment
1.6.3 Orthopedic pain treatment
1.6.4 Other pain treatment
1.7 Opioids Drugs Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Opioids Drugs Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter's Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Opioids Drugs Market
3.1 Value Chain Status
3.2 Opioids Drugs Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Opioids Drugs
3.2.3 Labor Cost of Opioids Drugs
3.2.3.1 Labor Cost of Opioids Drugs Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Allergan
4.1.1 Allergan Basic Information
4.1.2 Opioids Drugs Product Profiles, Application and Specification
4.1.3 Allergan Opioids Drugs Market Performance (2015-2020)
4.1.4 Allergan Business Overview
4.2 Orexo Pharmaceuticals
4.2.1 Orexo Pharmaceuticals Basic Information
4.2.2 Opioids Drugs Product Profiles, Application and Specification
4.2.3 Orexo Pharmaceuticals Opioids Drugs Market Performance (2015-2020)
4.2.4 Orexo Pharmaceuticals Business Overview
4.3 Purdue Pharma
4.3.1 Purdue Pharma Basic Information
4.3.2 Opioids Drugs Product Profiles, Application and Specification
4.3.3 Purdue Pharma Opioids Drugs Market Performance (2015-2020)
4.3.4 Purdue Pharma Business Overview
4.4 Pfizer
4.4.1 Pfizer Basic Information
4.4.2 Opioids Drugs Product Profiles, Application and Specification
4.4.3 Pfizer Opioids Drugs Market Performance (2015-2020)
4.4.4 Pfizer Business Overview
4.5 AbbVie
4.5.1 AbbVie Basic Information
4.5.2 Opioids Drugs Product Profiles, Application and Specification
4.5.3 AbbVie Opioids Drugs Market Performance (2015-2020)
4.5.4 AbbVie Business Overview
4.6 Teva pharmaceuticals
4.6.1 Teva pharmaceuticals Basic Information
4.6.2 Opioids Drugs Product Profiles, Application and Specification
4.6.3 Teva pharmaceuticals Opioids Drugs Market Performance (2015-2020)
4.6.4 Teva pharmaceuticals Business Overview
4.7 Johnson & Johnson
4.7.1 Johnson & Johnson Basic Information
4.7.2 Opioids Drugs Product Profiles, Application and Specification
4.7.3 Johnson & Johnson Opioids Drugs Market Performance (2015-2020)
4.7.4 Johnson & Johnson Business Overview
4.8 Endo Pharmaceuticals
4.8.1 Endo Pharmaceuticals Basic Information
4.8.2 Opioids Drugs Product Profiles, Application and Specification
4.8.3 Endo Pharmaceuticals Opioids Drugs Market Performance (2015-2020)
4.8.4 Endo Pharmaceuticals Business Overview
4.9 Sanofi-aventis US LLC
4.9.1 Sanofi-aventis US LLC Basic Information
4.9.2 Opioids Drugs Product Profiles, Application and Specification
4.9.3 Sanofi-aventis US LLC Opioids Drugs Market Performance (2015-2020)
4.9.4 Sanofi-aventis US LLC Business Overview
4.10 Hospira
4.10.1 Hospira Basic Information
4.10.2 Opioids Drugs Product Profiles, Application and Specification
4.10.3 Hospira Opioids Drugs Market Performance (2015-2020)
4.10.4 Hospira Business Overview

5 Global Opioids Drugs Market Analysis by Regions
5.1 Global Opioids Drugs Sales, Revenue and Market Share by Regions
5.1.1 Global Opioids Drugs Sales by Regions (2015-2020)
5.1.2 Global Opioids Drugs Revenue by Regions (2015-2020)
5.2 North America Opioids Drugs Sales and Growth Rate (2015-2020)
5.3 Europe Opioids Drugs Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Opioids Drugs Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Opioids Drugs Sales and Growth Rate (2015-2020)
5.6 South America Opioids Drugs Sales and Growth Rate (2015-2020)

6 North America Opioids Drugs Market Analysis by Countries
6.1 North America Opioids Drugs Sales, Revenue and Market Share by Countries
6.1.1 North America Opioids Drugs Sales by Countries (2015-2020)
6.1.2 North America Opioids Drugs Revenue by Countries (2015-2020)
6.1.3 North America Opioids Drugs Market Under COVID-19
6.2 United States Opioids Drugs Sales and Growth Rate (2015-2020)
6.2.1 United States Opioids Drugs Market Under COVID-19
6.3 Canada Opioids Drugs Sales and Growth Rate (2015-2020)
6.4 Mexico Opioids Drugs Sales and Growth Rate (2015-2020)

7 Europe Opioids Drugs Market Analysis by Countries
7.1 Europe Opioids Drugs Sales, Revenue and Market Share by Countries
7.1.1 Europe Opioids Drugs Sales by Countries (2015-2020)
7.1.2 Europe Opioids Drugs Revenue by Countries (2015-2020)
7.1.3 Europe Opioids Drugs Market Under COVID-19
7.2 Germany Opioids Drugs Sales and Growth Rate (2015-2020)
7.2.1 Germany Opioids Drugs Market Under COVID-19
7.3 UK Opioids Drugs Sales and Growth Rate (2015-2020)
7.3.1 UK Opioids Drugs Market Under COVID-19
7.4 France Opioids Drugs Sales and Growth Rate (2015-2020)
7.4.1 France Opioids Drugs Market Under COVID-19
7.5 Italy Opioids Drugs Sales and Growth Rate (2015-2020)
7.5.1 Italy Opioids Drugs Market Under COVID-19
7.6 Spain Opioids Drugs Sales and Growth Rate (2015-2020)
7.6.1 Spain Opioids Drugs Market Under COVID-19
7.7 Russia Opioids Drugs Sales and Growth Rate (2015-2020)
7.7.1 Russia Opioids Drugs Market Under COVID-19

8 Asia-Pacific Opioids Drugs Market Analysis by Countries
8.1 Asia-Pacific Opioids Drugs Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Opioids Drugs Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Opioids Drugs Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Opioids Drugs Market Under COVID-19
8.2 China Opioids Drugs Sales and Growth Rate (2015-2020)
8.2.1 China Opioids Drugs Market Under COVID-19
8.3 Japan Opioids Drugs Sales and Growth Rate (2015-2020)
8.3.1 Japan Opioids Drugs Market Under COVID-19
8.4 South Korea Opioids Drugs Sales and Growth Rate (2015-2020)
8.4.1 South Korea Opioids Drugs Market Under COVID-19
8.5 Australia Opioids Drugs Sales and Growth Rate (2015-2020)
8.6 India Opioids Drugs Sales and Growth Rate (2015-2020)
8.6.1 India Opioids Drugs Market Under COVID-19
8.7 Southeast Asia Opioids Drugs Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Opioids Drugs Market Under COVID-19

9 Middle East and Africa Opioids Drugs Market Analysis by Countries
9.1 Middle East and Africa Opioids Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Opioids Drugs Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Opioids Drugs Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Opioids Drugs Market Under COVID-19
9.2 Saudi Arabia Opioids Drugs Sales and Growth Rate (2015-2020)
9.3 UAE Opioids Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Opioids Drugs Sales and Growth Rate (2015-2020)
9.5 Nigeria Opioids Drugs Sales and Growth Rate (2015-2020)
9.6 South Africa Opioids Drugs Sales and Growth Rate (2015-2020)

10 South America Opioids Drugs Market Analysis by Countries
10.1 South America Opioids Drugs Sales, Revenue and Market Share by Countries
10.1.1 South America Opioids Drugs Sales by Countries (2015-2020)
10.1.2 South America Opioids Drugs Revenue by Countries (2015-2020)
10.1.3 South America Opioids Drugs Market Under COVID-19
10.2 Brazil Opioids Drugs Sales and Growth Rate (2015-2020)
10.2.1 Brazil Opioids Drugs Market Under COVID-19
10.3 Argentina Opioids Drugs Sales and Growth Rate (2015-2020)
10.4 Columbia Opioids Drugs Sales and Growth Rate (2015-2020)
10.5 Chile Opioids Drugs Sales and Growth Rate (2015-2020)

11 Global Opioids Drugs Market Segment by Types
11.1 Global Opioids Drugs Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Opioids Drugs Sales and Market Share by Types (2015-2020)
11.1.2 Global Opioids Drugs Revenue and Market Share by Types (2015-2020)
11.2 Oxycodone (e.g., OxyContin, Percocet) Sales and Price (2015-2020)
11.3 Hydrocodone (e.g., Vicodin) Sales and Price (2015-2020)
11.4 Codeine Sales and Price (2015-2020)
11.5 Morphine (e.g., Kadian, Avinza) Sales and Price (2015-2020)
11.6 Others Sales and Price (2015-2020)

12 Global Opioids Drugs Market Segment by Applications
12.1 Global Opioids Drugs Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Opioids Drugs Sales and Market Share by Applications (2015-2020)
12.1.2 Global Opioids Drugs Revenue and Market Share by Applications (2015-2020)
12.2 Neuropathic pain treatment Sales, Revenue and Growth Rate (2015-2020)
12.3 Orthopedic pain treatment Sales, Revenue and Growth Rate (2015-2020)
12.4 Other pain treatment Sales, Revenue and Growth Rate (2015-2020)

13 Opioids Drugs Market Forecast by Regions (2020-2026)
13.1 Global Opioids Drugs Sales, Revenue and Growth Rate (2020-2026)
13.2 Opioids Drugs Market Forecast by Regions (2020-2026)
13.2.1 North America Opioids Drugs Market Forecast (2020-2026)
13.2.2 Europe Opioids Drugs Market Forecast (2020-2026)
13.2.3 Asia-Pacific Opioids Drugs Market Forecast (2020-2026)
13.2.4 Middle East and Africa Opioids Drugs Market Forecast (2020-2026)
13.2.5 South America Opioids Drugs Market Forecast (2020-2026)
13.3 Opioids Drugs Market Forecast by Types (2020-2026)
13.4 Opioids Drugs Market Forecast by Applications (2020-2026)
13.5 Opioids Drugs Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source

List of Tables and Figures
Table Global Opioids Drugs Market Size Growth Rate by Type (2020-2026)
Figure Global Opioids Drugs Market Share by Type in 2019 & 2026
Figure Oxycodone (e.g., OxyContin, Percocet) Features
Figure Hydrocodone (e.g., Vicodin) Features
Figure Codeine Features
Figure Morphine (e.g., Kadian, Avinza) Features
Figure Others Features
Table Global Opioids Drugs Market Size Growth by Application (2020-2026)
Figure Global Opioids Drugs Market Share by Application in 2019 & 2026
Figure Neuropathic pain treatment Description
Figure Orthopedic pain treatment Description
Figure Other pain treatment Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Opioids Drugs Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Opioids Drugs Market Size and Growth Rate 2015-2026
Table Industry News
Table Industry Policies
Figure Value Chain Status of Opioids Drugs
Figure Production Process of Opioids Drugs
Figure Manufacturing Cost Structure of Opioids Drugs
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Allergan Profile
Table Allergan Production, Value, Price, Gross Margin 2015-2020
Table Orexo Pharmaceuticals Profile
Table Orexo Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Table Purdue Pharma Profile
Table Purdue Pharma Production, Value, Price, Gross Margin 2015-2020
Table Pfizer Profile
Table Pfizer Production, Value, Price, Gross Margin 2015-2020
Table AbbVie Profile
Table AbbVie Production, Value, Price, Gross Margin 2015-2020
Table Teva pharmaceuticals Profile
Table Teva pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Table Johnson & Johnson Profile
Table Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
Table Endo Pharmaceuticals Profile
Table Endo Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Table Sanofi-aventis US LLC Profile
Table Sanofi-aventis US LLC Production, Value, Price, Gross Margin 2015-2020
Table Hospira Profile
Table Hospira Production, Value, Price, Gross Margin 2015-2020
Figure Global Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Global Opioids Drugs Revenue ($) and Growth (2015-2020)
Table Global Opioids Drugs Sales by Regions (2015-2020)
Table Global Opioids Drugs Sales Market Share by Regions (2015-2020)
Table Global Opioids Drugs Revenue ($) by Regions (2015-2020)
Table Global Opioids Drugs Revenue Market Share by Regions (2015-2020)
Table Global Opioids Drugs Revenue Market Share by Regions in 2015
Table Global Opioids Drugs Revenue Market Share by Regions in 2019
Figure North America Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Europe Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Opioids Drugs Sales and Growth Rate (2015-2020)
Figure South America Opioids Drugs Sales and Growth Rate (2015-2020)
Figure North America Opioids Drugs Revenue ($) and Growth (2015-2020)
Table North America Opioids Drugs Sales by Countries (2015-2020)
Table North America Opioids Drugs Sales Market Share by Countries (2015-2020)
Figure North America Opioids Drugs Sales Market Share by Countries in 2015
Figure North America Opioids Drugs Sales Market Share by Countries in 2019
Table North America Opioids Drugs Revenue ($) by Countries (2015-2020)
Table North America Opioids Drugs Revenue Market Share by Countries (2015-2020)
Figure North America Opioids Drugs Revenue Market Share by Countries in 2015
Figure North America Opioids Drugs Revenue Market Share by Countries in 2019
Figure United States Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Canada Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Mexico Opioids Drugs Sales and Growth (2015-2020)
Figure Europe Opioids Drugs Revenue ($) Growth (2015-2020)
Table Europe Opioids Drugs Sales by Countries (2015-2020)
Table Europe Opioids Drugs Sales Market Share by Countries (2015-2020)
Figure Europe Opioids Drugs Sales Market Share by Countries in 2015
Figure Europe Opioids Drugs Sales Market Share by Countries in 2019
Table Europe Opioids Drugs Revenue ($) by Countries (2015-2020)
Table Europe Opioids Drugs Revenue Market Share by Countries (2015-2020)
Figure Europe Opioids Drugs Revenue Market Share by Countries in 2015
Figure Europe Opioids Drugs Revenue Market Share by Countries in 2019
Figure Germany Opioids Drugs Sales and Growth Rate (2015-2020)
Figure UK Opioids Drugs Sales and Growth Rate (2015-2020)
Figure France Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Italy Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Spain Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Russia Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Opioids Drugs Revenue ($) and Growth (2015-2020)
Table Asia-Pacific Opioids Drugs Sales by Countries (2015-2020)
Table Asia-Pacific Opioids Drugs Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific Opioids Drugs Sales Market Share by Countries in 2015
Figure Asia-Pacific Opioids Drugs Sales Market Share by Countries in 2019
Table Asia-Pacific Opioids Drugs Revenue ($) by Countries (2015-2020)
Table Asia-Pacific Opioids Drugs Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Opioids Drugs Revenue Market Share by Countries in 2015
Figure Asia-Pacific Opioids Drugs Revenue Market Share by Countries in 2019
Figure China Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Japan Opioids Drugs Sales and Growth Rate (2015-2020)
Figure South Korea Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Australia Opioids Drugs Sales and Growth Rate (2015-2020)
Figure India Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Southeast Asia Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Opioids Drugs Revenue ($) and Growth (2015-2020)
Table Middle East and Africa Opioids Drugs Sales by Countries (2015-2020)
Table Middle East and Africa Opioids Drugs Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Opioids Drugs Revenue ($) by Countries (2015-2020)
Table Middle East and Africa Opioids Drugs Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Opioids Drugs Revenue Market Share by Countries in 2015
Figure Middle East and Africa Opioids Drugs Revenue Market Share by Countries in 2019
Figure Saudi Arabia Opioids Drugs Sales and Growth Rate (2015-2020)
Figure UAE Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Egypt Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Nigeria Opioids Drugs Sales and Growth Rate (2015-2020)
Figure South Africa Opioids Drugs Sales and Growth Rate (2015-2020)
Figure South America Opioids Drugs Revenue ($) and Growth (2015-2020)
Table South America Opioids Drugs Sales by Countries (2015-2020)
Table South America Opioids Drugs Sales Market Share by Countries (2015-2020)
Table South America Opioids Drugs Revenue ($) by Countries (2015-2020)
Table South America Opioids Drugs Revenue Market Share by Countries (2015-2020)
Figure South America Opioids Drugs Revenue Market Share by Countries in 2015
Figure South America Opioids Drugs Revenue Market Share by Countries in 2019
Figure Brazil Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Argentina Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Columbia Opioids Drugs Sales and Growth Rate (2015-2020)
Figure Chile Opioids Drugs Sales and Growth Rate (2015-2020)
Table Global Opioids Drugs Sales by Types (2015-2020)
Table Global Opioids Drugs Sales Share by Types (2015-2020)
Table Global Opioids Drugs Revenue ($) by Types (2015-2020)
Table Global Opioids Drugs Revenue Share by Types (2015-2020)
Figure Global Oxycodone (e.g., OxyContin, Percocet) Sales and Growth Rate (2015-2020)
Figure Global Oxycodone (e.g., OxyContin, Percocet) Price (2015-2020)
Figure Global Hydrocodone (e.g., Vicodin) Sales and Growth Rate (2015-2020)
Figure Global Hydrocodone (e.g., Vicodin) Price (2015-2020)
Figure Global Codeine Sales and Growth Rate (2015-2020)
Figure Global Codeine Price (2015-2020)
Figure Global Morphine (e.g., Kadian, Avinza) Sales and Growth Rate (2015-2020)
Figure Global Morphine (e.g., Kadian, Avinza) Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Opioids Drugs Sales by Applications (2015-2020)
Table Global Opioids Drugs Sales Share by Applications (2015-2020)
Figure Global Neuropathic pain treatment Sales and Growth Rate (2015-2020)
Figure Global Neuropathic pain treatment Revenue and Growth Rate (2015-2020)
Figure Global Orthopedic pain treatment Sales and Growth Rate (2015-2020)
Figure Global Orthopedic pain treatment Revenue and Growth Rate (2015-2020)
Figure Global Other pain treatment Sales and Growth Rate (2015-2020)
Figure Global Other pain treatment Revenue and Growth Rate (2015-2020)
Figure Global Opioids Drugs Sales and Growth Rate (2020-2026)
Figure Global Opioids Drugs Revenue ($) and Growth Rate (2020-2026)
Table Global Opioids Drugs Sales Forecast by Regions (2020-2026)
Table Global Opioids Drugs Revenue Forecast by Regions (2020-2026)
Figure North America Opioids Drugs Sales Forecast (2020-2026)
Figure North America Opioids Drugs Revenue Forecast (2020-2026)
Figure Europe Opioids Drugs Sales Forecast (2020-2026)
Figure Europe Opioids Drugs Revenue Forecast (2020-2026)
Figure Asia-Pacific Opioids Drugs Sales Forecast (2020-2026)
Figure Asia-Pacific Opioids Drugs Revenue Forecast (2020-2026)
Figure Middle East and Africa Opioids Drugs Sales Forecast (2020-2026)
Figure Middle East and Africa Opioids Drugs Revenue Forecast (2020-2026)
Figure South America Opioids Drugs Sales Forecast (2020-2026)
Figure South America Opioids Drugs Revenue Forecast (2020-2026)
Table Global Opioids Drugs Sales Forecast by Types (2020-2026)
Table Global Opioids Drugs Sales Market Share Forecast by Types (2020-2026)
Table Global Opioids Drugs Revenue Forecast by Types (2020-2026)
Table Global Opioids Drugs Revenue Market Share Forecast by Types (2020-2026)
Table Global Opioids Drugs Sales Forecast by Applications (2020-2026)
Table Global Opioids Drugs Sales Market Share Forecast by Applications (2020-2026)
Table Global Opioids Drugs Revenue Forecast by Applications (2020-2026)
Table Global Opioids Drugs Revenue Market Share Forecast by Applications (2020-2026)

  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs